In Vitro and in Vivo Antitumor Effects of the Recombinant Immunotoxin IL6(T23)-PE38KDEL in Multiple Myeloma

Oncology Letters - Greece
doi 10.3892/ol.2012.733
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

In Vitro and in Vivo Studies of Antitumor Effects of the Recombinant Immunotoxin MSH-PE38KDEL on Melanoma

Neoplasma
Cancer Research
2014English

Sorafenib Has Potent Antitumor Activity Against Multiple Myeloma in Vitro, Ex Vivo, and in Vivo in the 5T33MM Mouse Model

Cancer Research
Cancer ResearchOncology
2012English

Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

The Novel Immunotoxin HM1.24-ETA′ Induces Apoptosis in Multiple Myeloma Cells

Blood Cancer Journal
OncologyHematology
2014English

Potent in Vitro and in Vivo Effects of Polyclonal Anti-Human-Myeloma Globulins

Oncotarget
Oncology
2016English

Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel in Vitro and in Vivo

PLoS ONE
Multidisciplinary
2011English

Flavopiridol Enhances ABT-199 Sensitivity in Unfavourable-Risk Multiple Myeloma Cells in Vitro and in Vivo

British Journal of Cancer
Cancer ResearchOncology
2017English

Caffeine Citrate Enhanced Cisplatin Antitumor Effects in Osteosarcoma and Fibrosarcoma in Vitro and in Vivo

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Multiple Myeloma—An in Vitro Study

British Journal of Cancer
Cancer ResearchOncology
1961English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy